Market Overview:
The global oxytocic pharmaceutical market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for oxytocin drugs for various applications such as labor induction, postpartum hemorrhage, and others. In addition, the increasing awareness about the benefits of oxytocin drugs is also contributing to the growth of this market. On the basis of type, natural oxytocin accounted for a major share of the global oxytocic pharmaceutical market in 2017. This can be attributed to its numerous benefits over synthetic oxytocin derivatives. However, synthetic oxygen derivatives are expected to grow at a higher CAGR during 2018-2030 owing their advantages over natural oxygen derivatives such as longer shelf life and easy availability. Based on application, hospitals held a dominant share of the global Oxytic Pharmaceutical Market in 2017 and is projected to maintain its dominance during 2018-2030 period owing rising number childbirths across globe coupled with growing preference for hospital delivery over home delivery among pregnant women’s globally .
Product Definition:
Oxytocic Pharmaceutical is a drug that causes uterine contractions. It is used to induce labor, to speed up labor, or to prevent post-partum hemorrhage.
Natural Oxytocin:
Oxytocin is a hormone, which is produced in the human body. It plays an important role in childbirth and breastfeeding. The drug has several other uses as well such as it helps to stimulate the formation of emotional bonds between people, promotes social distancing behavior among species and induces vomiting for motion sickness.
The global market for oxytocin (Latin: Oxytoca) was valued at USD 683 million in 2016.
Synthetic Oxytocin Derivative:
Synthetic Oxytocin Derivative (oxytocin) is a drug that is used to induce labor and it's also used as an anti-epileptic. It works by increasing the sensitivity of the oxytocin receptor which causes contractions during childbirth. Synthetic oxytocin has been approved by Health Canada for use in inducing labor, however, it has not been approved for use as an anti-epileptic.
Application Insights:
Based on the application, the market is segmented into hospitals, maternity clinics and others. The other applications include labor & delivery rooms and OPD settings. In 2017, hospital dominated the overall industry with a revenue share of over 60%. This can be attributed to an increase in cesarean deliveries which leads to increased demand for Oxytocin nasal spray for inducing labor.
The increasing number of cesarean deliveries has led to an increased need for non-invasive methods of birth such as cervical cerclage or forceps which also increases market penetration in maternity clinics. Furthermore, rising awareness about childbirth among women coupled with easy access to healthcare facilities will boost product demand in these settings during pregnancy as well as postpartum period.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in social media and online shopping. The region is expected to maintain its position during the forecast period due to increasing awareness about birth control, abortion, and other related issues. Asia Pacific is estimated to be the fastest-growing region over the forecast period owing to rising population and demand for contraceptives among women. In addition, growing medical tourism due to affordable healthcare services offered by countries such as India will drive growth of this regional market. Latin America also presents significant growth opportunities for oxytocic pharmaceuticals on account of high prevalence of maternal disorders coupled with limited availability of effective contraceptive methods that do not involve surgery or drugs that affect fertility rates (such as Depo-Provera).
Growth Factors:
- Increasing awareness about the benefits of oxytocin for pregnant women and newborns is likely to drive the growth of the oxytocic pharmaceutical market.
- Rising demand for oxytocin drugs for labor induction is also expected to propel the growth of this market in the near future.
- Growing number of Cesarean sections across the globe is anticipated to create lucrative opportunities for players operating in this market over the next few years.
- Increasing investments by key players in research and development activities are likely to boost growth prospects of this market in coming years.
- Rapid expansion of hospitals and clinics across emerging economies is projected to fuel demand for oxytocic drugs over next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
Oxytocic Pharmaceutical Market Research Report
By Type
Natural Oxytocin, Synthetic Oxytocin Derivative
By Application
Hospitals, Maternity Clinics
By Companies
Fresenius Kaci, Biofutura, Baxter Healthcare, Pfizer, Ferring, Novartis, Teva Pharmaceutical Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Oxytocic Pharmaceutical Market Report Segments:
The global Oxytocic Pharmaceutical market is segmented on the basis of:
Types
Natural Oxytocin, Synthetic Oxytocin Derivative
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Maternity Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fresenius Kaci
- Biofutura
- Baxter Healthcare
- Pfizer
- Ferring
- Novartis
- Teva Pharmaceutical Industries
Highlights of The Oxytocic Pharmaceutical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Natural Oxytocin
- Synthetic Oxytocin Derivative
- By Application:
- Hospitals
- Maternity Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oxytocic Pharmaceutical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oxytocin is a hormone that is produced in the hypothalamus and released into the bloodstream. Oxytocin has been shown to have a variety of effects on behavior, including promoting childbirth, calming anxiety, and reducing stress. Oxytocin pharmaceuticals are medications that contain oxytocin as their main active ingredient. These medications are used to treat conditions such as autism spectrum disorder (ASD), post-traumatic stress disorder (PTSD), and social anxiety disorder (SAD).
Some of the major companies in the oxytocic pharmaceutical market are Fresenius Kaci, Biofutura, Baxter Healthcare, Pfizer, Ferring, Novartis, Teva Pharmaceutical Industries.
The oxytocic pharmaceutical market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oxytocic Pharmaceutical Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oxytocic Pharmaceutical Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oxytocic Pharmaceutical Market - Supply Chain
4.5. Global Oxytocic Pharmaceutical Market Forecast
4.5.1. Oxytocic Pharmaceutical Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oxytocic Pharmaceutical Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oxytocic Pharmaceutical Market Absolute $ Opportunity
5. Global Oxytocic Pharmaceutical Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oxytocic Pharmaceutical Market Size and Volume Forecast by Type
5.3.1. Natural Oxytocin
5.3.2. Synthetic Oxytocin Derivative
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oxytocic Pharmaceutical Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oxytocic Pharmaceutical Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Maternity Clinics
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oxytocic Pharmaceutical Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oxytocic Pharmaceutical Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oxytocic Pharmaceutical Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oxytocic Pharmaceutical Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oxytocic Pharmaceutical Demand Share Forecast, 2019-2026
9. North America Oxytocic Pharmaceutical Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oxytocic Pharmaceutical Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oxytocic Pharmaceutical Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Maternity Clinics
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oxytocic Pharmaceutical Market Size and Volume Forecast by Type
9.7.1. Natural Oxytocin
9.7.2. Synthetic Oxytocin Derivative
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oxytocic Pharmaceutical Demand Share Forecast, 2019-2026
10. Latin America Oxytocic Pharmaceutical Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oxytocic Pharmaceutical Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oxytocic Pharmaceutical Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Maternity Clinics
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oxytocic Pharmaceutical Market Size and Volume Forecast by Type
10.7.1. Natural Oxytocin
10.7.2. Synthetic Oxytocin Derivative
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oxytocic Pharmaceutical Demand Share Forecast, 2019-2026
11. Europe Oxytocic Pharmaceutical Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oxytocic Pharmaceutical Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oxytocic Pharmaceutical Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Maternity Clinics
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oxytocic Pharmaceutical Market Size and Volume Forecast by Type
11.7.1. Natural Oxytocin
11.7.2. Synthetic Oxytocin Derivative
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projectionsby Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oxytocic Pharmaceutical Demand Share, 2019-2026
12. Asia Pacific Oxytocic Pharmaceutical Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oxytocic Pharmaceutical Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oxytocic Pharmaceutical Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Maternity Clinics
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oxytocic Pharmaceutical Market Size and Volume Forecast by Type
12.7.1. Natural Oxytocin
12.7.2. Synthetic Oxytocin Derivative
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oxytocic Pharmaceutical Demand Share, 2019-2026
13. Middle East & Africa Oxytocic Pharmaceutical Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oxytocic Pharmaceutical Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oxytocic Pharmaceutical Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Maternity Clinics
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oxytocic Pharmaceutical Market Size and Volume Forecast by Type
13.7.1. Natural Oxytocin
13.7.2. Synthetic Oxytocin Derivative
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oxytocic Pharmaceutical Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oxytocic Pharmaceutical Market: Market Share Analysis
14.2. Oxytocic Pharmaceutical Distributors and Customers
14.3. Oxytocic Pharmaceutical Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Fresenius Kaci
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Biofutura
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Baxter Healthcare
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pfizer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Ferring
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Novartis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Teva Pharmaceutical Industries
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook